Platform under the thinking of pharmaceutical r&d innovation (below)

Release date: 2016-08-31 14:33:19

Source: web | author: furen Zhu Wenchen chairman

Throughout the history of the ricci group we major in pharmaceutical r&d development has experienced three phases:

According to the first stage, we vertical value chain to build their own research and development platform, at that time, in order to "go to BianJieHua", taking "no research institute of the fence" development strategy, through the enterprise merger and acquisition form of cooperation, taking big capacity, product line, so there will be a "fu ren 1000 doses of today.

Developed by the second phase, furen began to focus on new drugs quickly imitation innovation, and established the national local joint key laboratory, pilot technology innovation medicine incubation bases, chemical medicine preparation, Chinese traditional medicine pilot technology active ingredient extraction and purification, pharmaceutical preparations pilot state-level enterprise technology center, postdoctoral research station, and many other research and development and support platform. This stage how we consider more in the country and the restructuring of the world all kinds of medical resources integration for the development of Chinese medicine industry. In 2009, fu jen and specializes in gene drug development and production of Beijing policy pharmaceutical signed a strategic cooperation agreement, and the implementation of asset reorganization. As the virus biological technology national engineering research center of the affiliated enterprise, far policy of pharmaceutical industry in the field of biomedical research in a leading level in domestic and the world, furen began to occupy a place in the field of biological pharmacy. In 2012, fu jen and India's biggest anti-tumor and anti-hiv drugs by large multinational pharmaceutical company xian deron company strategic cooperation, joint venture "fu ren pharmaceutical group city deron tumor pharmaceutical co., LTD., the high-end antineoplastic drugs and AIDS drugs research and development, the introduction of domestic production, introducing furen, make up for us in anti-tumor, anti-hiv drugs in the field of research and development, production.

The third stage, we use the Shared economic thinking to develop r&d platform strategy, "no walls institute" development strategy for sublimation. Transform research begins with the vertical value chain thinking is the thinking in bilateral market, truly pharmaceutical research and development institutions "to BianJieHua", "decentralization" and "go" in the middle. Through structures, cooperation, win-win development platform, to form a siphon power, make the other resources close to us, in aspects of capital, products, technology, talent resource synergy, Shared economic model. The drug discovery furen is Shanghai construction science and technology park is a foothold in China and world development platform, the future it will form a new drug research and development innovation business incubators, drug research and development teams around the world to provide project development services. Here, we plan to attract 100 overseas returnees in the field of pharmaceutical research and development, Dr Or institutions in the platform, at the same time, we will also for the r&d base configuration 2000 r&d personnel, in order to solve the problem of drug research and development innovation required high-end talent, for subsequent sequencing work, such as drug discovery, drug design, preclinical research, clinical research and eventually international registration of the drug, etc. Project leader found only on this platform, establish new projects, and make breakthroughs, fu jen can directly for their new drug research through each link, to realize the industrialization and commercialization of products, by sharing the economic thought mode, build a siphon power industry value chain, promoting coordination innovation of research and development platform.

At the same time, we through the way such as equity allocation within the platform, use the combination of modular work to attract more high-end talent into. The thinking in the drug discovery of science and technology garden, platform has not only embodied in the strategic level, and applied to the organization's management, innovation, arouse the enthusiasm of staff. Through small marketization in-house or internal business practices, the internal agency organization mode between people from his organization to the organization, create win-win platform internal innovation ecosystem, by improving the personnel engaged and encouraged to stimulate their self innovation, and can share the fruits of innovation. At present the research and development platform has been attracted into world-class medical experts, some of the big stage in the process of new drug varieties are hatching.

Shared economic mode, the open platform for the enterprise development and innovation management mechanism is the key to pharmaceutical enterprise fast development, in this process, create loose innovation environment and the system is the innovation of an enterprise, it needs to push and the humanities spirit nourishing of systems and mechanisms, enterprise also need to stick to the innovation as a faith, constantly input resources, and on the premise of keep a clear determination.

Road endless innovation, in this long and winding road, furen pharmaceutical group will adhere to innovation, production, marketing the basic function of enterprise, steadfast to do work, the three aspects of accumulated in enterprise development source power, the enhancement enterprise core competitive power for the people made good medicine, rest assured.